At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 11 enrolled
Drug / intervention
Phenoxymethyl Penicillin +1 moredrug
Likely dose
Phenoxymethyl Penicillin 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Microneedle Sensing of Beta-lactam Antibiotic Concentrations in Human Interstitial Fluid
In Brief
A Phase 1 clinical trial evaluating Phenoxymethyl Penicillin and Microneedle array for Healthy Volunteers. Completed, enrolled 11 participants across 1 site.
Detailed Summary
This study is an in-house feasibility study of a microneedle biosensor developed within Imperial College London.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 1CompletedFinished
20192020202120222023202420252026
Enrollment StartApr 2018
Primary CompletionAug 2018
First PostedFeb 2019
TodayJul 2026
First PostedFeb 20, 2019
Enrollment StartApr 12, 2018
Primary CompletionAug 10, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.4 years ago
Interventions
Phenoxymethyl Penicillindrug
Phenoxymethylpenicillin tablets, 500mg every six hours for six doses, starting the day before study
Microneedle arraydevice
The microneedle biosensor will be sited peripherally (on the non-dominant arm) for the duration of the study. It will then be removed.